Global Neuro-Auto-Immune Disease Diagnostics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Diagnostics Test;
Antinuclear Antibodies (ANA) Test, Autoantibodies Test, Blood Test: Immunoglobulin A (IgA) Test, C-Reactive Protein (CRP) Test, Complement Test, ESR (erythrocyte sedimentation rate) Test and Protein Electrophoresis Test Or Immunofixation Electrophoresis Test.Segmented by End User;
Hospitals, Neurological Diagnostics Test Centers and Others.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Neuro-Auto-Immune Disease Diagnostics Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 101.0 |
2021 | 105.5 |
2022 | 119.4 |
2023 | 121.9 |
2024 | 141.0 |
2025 | 145.1 |
2026 | 163.6 |
2027 | 194.4 |
2028 | 230.9 |
2029 | 231.6 |
2030 | 268.0 |
In the year 2023, the Global Neuro-Auto-Immune Disease Diagnostics Market was valued at USD 1,698.30 million. The size of this market is expected to increase to USD 2,808.03 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.4%.
Global Neuro-Auto-Immune Disease Diagnostics Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Neuro-Auto-Immune Disease Diagnostics Market |
Study Period | 2020 - 2030 |
Base Year (for Neuro-Auto-Immune Disease Diagnostics Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Neuro-Auto-Immune Disease Diagnostics Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Neuro-Auto-Immune Disease Diagnostics Market Analysis
In this report, the Global Neuro-Auto-Immune Disease Diagnostics Market has been segmented by Diagnostics Test, End User and Geography. Multiple sclerosis, acute disseminated encephalomyelitis, autoimmune encephalitis, acute myelitis, neuromyelitis optica, guillain-barré syndrome, and myasthenia gravis are among the neurological autoimmune diseases. Autoimmune encephalitis is a group of conditions that occur when the body's immune system incorrectly attacks healthy brain cells, resulting in brain inflammation. Adult neuroimmune disorders are an umbrella term for a group of diseases that involve both immune and nervous system dysfunction. Autoimmune neurologic disorders can be diverse and difficult to identify in their early stages, further complicating diagnosis. The neuro auto blood test measures the levels of therapeutic drugs used to treat epilepsy and other neurological disorders. A comprehensive panel of autoimmune neurology antibodies is a set of tests used to screen for autoimmune liver disease. An autoimmune liver disease occurs when the immune system of the body attacks the liver. Acute disseminated encephalomyelitis, acute flaccid myelitis, mog antibody disease, neuromyelitis optica spectrum disorder, optic neuritis, and transverse myelitis are a few rare neurological autoimmune diseases.
Global Neuro-Auto-Immune Disease Diagnostics Market, Segmentation by Diagnostics Test
The Global Neuro-Auto-Immune Disease Diagnostics Market has been segmented by Diagnostics Test into Antinuclear Antibodies (ANA) Test, Autoantibodies Test, Blood Test: Immunoglobulin A (IgA) Test, C-Reactive Protein (CRP) Test, Complement Test, ESR (erythrocyte sedimentation rate) Test and Protein Electrophoresis Test Or Immunofixation Electrophoresis Test. The complete Global Neuro-Auto-Immune Disease Diagnostics Market segmentation by Diagnostics Test can be seen below:
- Global Neuro-Auto-Immune Disease Diagnostics Market, By Diagnostics Test
- Antinuclear Antibodies (ANA) Test
- Autoantibodies Test
- Blood Test: Immunoglobulin A (IgA) Test
- C-Reactive Protein (CRP) Test
- Complement Test
- ESR (erythrocyte sedimentation rate) Test
- Protein Electrophoresis Test Or Immunofixation Electrophoresis Test
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Diagnostics Tests mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Diagnostics Test is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neuro-Auto-Immune Disease Diagnostics Market, by Diagnostics Test (USD Million), 2020 - 2030
# | Antinuclear Antibodies (ANA) Test | Autoantibodies Test | Blood Test: Immunoglobulin A (IgA) Test | C-Reactive Protein (CRP) Test | Complement Test | ESR (erythrocyte sedimentation rate) Test | Protein Electrophoresis Test Or Immunofixation Electrophoresis Test |
---|---|---|---|---|---|---|---|
2020 | 74.5 | 65.6 | 108.2 | 83.1 | 108.7 | 74.8 | 81.5 |
2021 | 87.2 | 74.2 | 118.6 | 93.2 | 121.7 | 76.0 | 97.2 |
2022 | 101.1 | 87.7 | 137.9 | 110.8 | 140.6 | 88.6 | 98.8 |
2023 | 109.0 | 87.7 | 152.4 | 124.0 | 154.4 | 93.6 | 117.0 |
2024 | 128.4 | 101.5 | 158.2 | 141.1 | 155.3 | 102.5 | 130.7 |
2025 | 142.8 | 118.0 | 179.3 | 152.0 | 163.1 | 117.4 | 133.6 |
2026 | 168.8 | 129.5 | 184.2 | 173.8 | 193.8 | 127.5 | 136.0 |
2027 | 182.7 | 148.5 | 204.9 | 185.5 | 215.1 | 132.1 | 151.5 |
2028 | 187.8 | 170.6 | 240.8 | 192.6 | 240.7 | 139.3 | 156.8 |
2029 | 217.4 | 175.4 | 266.6 | 228.6 | 280.8 | 144.1 | 159.9 |
2030 | 253.3 | 202.5 | 281.7 | 267.4 | 309.5 | 170.7 | 171.5 |
Global Neuro-Auto-Immune Disease Diagnostics Market, Segmentation by End User
The Global Neuro-Auto-Immune Disease Diagnostics Market has been segmented by End User into Hospitals, Neurological Diagnostics Test Centers and Others. The complete Global Neuro-Auto-Immune Disease Diagnostics Market segmentation by End User can be seen below:
- Global Neuro-Auto-Immune Disease Diagnostics Market, By End User
- Hospitals
- Neurological Diagnostics Test Centers
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Users mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End User is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Neuro-Auto-Immune Disease Diagnostics Market, by End User (USD Million), 2020 - 2030
# | Hospitals | Neurological Diagnostics Test Centers | Others |
---|---|---|---|
2020 | 72.2 | 86.9 | 96.5 |
2021 | 76.6 | 90.2 | 113.7 |
2022 | 83.2 | 93.3 | 120.2 |
2023 | 83.8 | 99.3 | 123.7 |
2024 | 86.9 | 113.2 | 137.4 |
2025 | 94.2 | 125.4 | 163.3 |
2026 | 95.7 | 145.4 | 189.2 |
2027 | 114.7 | 153.5 | 204.5 |
2028 | 133.0 | 182.7 | 240.5 |
2029 | 157.8 | 205.3 | 271.4 |
2030 | 172.2 | 238.3 | 322.1 |
Global Neuro-Auto-Immune Disease Diagnostics Market, Segmentation by Geography
In this report, the Global Neuro-Auto-Immune Disease Diagnostics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Neuro-Auto-Immune Disease Diagnostics Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Neuro-Auto-Immune Disease Diagnostics Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Neuro-Auto-Immune Disease Diagnostics in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Neuro-Auto-Immune Disease Diagnostics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Neuro-Auto-Immune Disease Diagnostics Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Neuro-Auto-Immune Disease Diagnostics Market will be discussed in detail in the full report.
- The new opportunities in Global Neuro-Auto-Immune Disease Diagnostics Market will be discussed in detail in the full report.
- Global Neuro-Auto-Immune Disease Diagnostics Market Drivers will be discussed in detail in the full report.
- Global Neuro-Auto-Immune Disease Diagnostics Market Restraints will be discussed in detail in the full report.
- Global Neuro-Auto-Immune Disease Diagnostics Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Neuro-Auto-Immune Disease Diagnostics Market. The opportunity map (by market segments; Diagnostics Test and End User) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Neuro-Auto-Immune Disease Diagnostics Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Neuro-Auto-Immune Disease Diagnostics Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Neuro-Auto-Immune Disease Diagnostics Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Neuro-Auto-Immune Disease Diagnostics Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Electric vehicle inverter manufacturers are continental ag, robert bosch gmbh, denso corporation, toyota industries. Smoothie industry manufacturers are mty food group, smoothie king, the coca-cola company, pepsico inc. Top manufacturers in yogurt industry are danone, nestl, parmalat s.P.A., yakult, chobani llc, yoplait, arla foods, mller, britannia industries limited, and frieslandcampina. Few listed contract manufacturing companies in india are amri india pvt. Ltd, dr. Reddy's laboratories, cadila healthcare limited, msn laboratories pvt ltd, viatris inc, medipaams india pvt ltd. Few pharma otc companies are glaxosmithkline plc, emami limited, abbott laboratories, dabur india limited, procter & gamble. Few steam turbine manufacturers in world are siemens ag, general electric company, dongfang turbine company limited, bharat heavy electricals limited. Few municipal solid waste management companies in india are a2z green waste management ltd, bvg india ltd, ecowise waste management pvt. Ltd, ecogreen energy pvt. Ltd, hanjer biotech energies pvt. Ltd.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Neuro-Auto-Immune Disease Diagnostics Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Neuro-Auto-Immune Disease Diagnostics Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Neuro-Auto-Immune Disease Diagnostics Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Neuro-Auto-Immune Disease Diagnostics Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Neuro-Auto-Immune Disease Diagnostics Market include, Bio-Rad Laboratories, Inc, Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, Abbott Diagnostics, Beckman Coulter, Inc., SQI Diagnostic and Euroimmun.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Diagnostics Test
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Opportunity Map
- Global Neuro-Auto-Immune Disease Diagnostics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Neuro-Auto-Immune Disease Diagnostics Market, By Diagnostics Test, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Antinuclear Antibodies (ANA) Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Autoantibodies Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Blood Test: Immunoglobulin A (IgA) Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- C-Reactive Protein (CRP) Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Complement Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- ESR (erythrocyte sedimentation rate) Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Protein Electrophoresis Test Or Immunofixation Electrophoresis Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Antinuclear Antibodies (ANA) Test
- Global Neuro-Auto-Immune Disease Diagnostics Market, By End User, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Neurological Diagnostics Test Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hospitals
- Global Neuro-Auto-Immune Disease Diagnostics Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Test, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Neuro-Auto-Immune Disease Diagnostics Market, By Diagnostics Test, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Bio-Rad Laboratories, Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Crescendo Bioscience
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Roche Diagnostics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Quest Diagnostics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott Diagnostics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Beckman Coulter, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- SQI Diagnostic
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Euroimmun.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bio-Rad Laboratories, Inc
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Neuroblastoma Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Neurocutaneous Disorder Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Neuroendocrine Carcinoma Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Neuroendocrine Carcinoma Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%